Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Sportradar files for IPO following SPAC flop, SomaLogic and Twist Bioscience announce partnership to create novel antibodies, and Swvl buys on-demand bus service Shotl
Sportradar Files for U.S. IPO After SPAC Merger Flops
Sports data provider Sportradar Group AG has filed for an IPO in the U.S. after merger talks with a SPAC collapsed.
The company, based in St. Gallen, Switzerland, in its filing Tuesday with the U.S. SEC listed the size of offering as $100 million, a placeholder that will likely change. Sportradar had held talks with Horizon Acquisition Corp. II (NYSE:HZAC), a blank-check company started by Eldridge Industries co-founder Todd Boehly.
READSomaLogic And Twist Bioscience Corporation Announce Partnership To Discover Novel Therapeutic Targets and Antibodies
CM Life Sciences II (NASDAQ: CMIIU) and proteomics technology leader SomaLogic, Inc. and Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration aimed at creating novel antibodies and enabling innovative drug discovery based on key disease biomarkers.
The collaboration will allow Twist to use the SomaScan® Platform to quickly identify antibodies against targets resulting from SomaLogic’s industry-leading 7,000-plex assay, believed to be one of the broadest views of the proteome available.
READSwvl Buys On-Demand Bus Service Shotl
Dubai-based transport startup Swvl has agreed to buy Shotl, an Uber-like service for bus and van operators that caters to municipalities, corporations and educational institutions, a source familiar with the matter told Reuters.
Swvl last month agreed to merge with blank check firm Queen’s Gambit Growth Capital, setting the stage for a Nasdaq listing in the fourth quarter of this year.
READPlanet And Google Cloud Partner To Bring Planetary-Scale Satellite Data Analysis To Governments and Enterprises
Under a new agreement, Google Cloud will collaborate with Planet to create joint solutions that combine Planet’s high-frequency Earth observation data with Google Cloud’s cloud-based infrastructure to enable better data-driven decision-making.
Last month, Planet entered into a definitive merger agreement with dMY Technology Group, Inc. IV (NYSE:DMYQ), a SPAC, to become a publicly-traded company.
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...